20-44414663-G-C
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PP4PM2_SupportingPVS1_Strong
This summary comes from the ClinGen Evidence Repository: The c.582+1G>C variant in the hepatocyte nuclear factor-4 alpha gene, HNF4A, is predicted to remove a canonical splice donor site in intron 5 of transcript NM_175914.5. This variant is predicted to cause an in-frame deletion of the biologically-relevant exon 5 of 10, removing more than 10% of the protein (PVS1_Strong; PMID:23348805). Additionally, this variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was also identified in an individual with a clinical history suggestive of HNF4A-MODY (neonatal hypoglycemia that is responsive to diazoxide with negative genetic testing for ABCC8 and KCNJ11)(PP4; internal lab contributors). In summary, c.582+1G>C, meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.0.0, approved 11/16/2022): PVS1_Strong, PM2_Supporting, PP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA409106289/MONDO:0015967/085
Frequency
Consequence
NM_175914.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- maturity-onset diabetes of the young type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- monogenic diabetesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- diabetes mellitus, noninsulin-dependentInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- Fanconi renotubular syndrome 4 with maturity-onset diabetes of the youngInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
- hyperinsulinism due to HNF4A deficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- maturity-onset diabetes of the youngInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_175914.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HNF4A | NM_175914.5 | MANE Select | c.582+1G>C | splice_donor intron | N/A | NP_787110.2 | |||
| HNF4A | NM_000457.6 | c.648+1G>C | splice_donor intron | N/A | NP_000448.3 | ||||
| HNF4A | NM_001258355.2 | c.627+1G>C | splice_donor intron | N/A | NP_001245284.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HNF4A | ENST00000316673.9 | TSL:1 MANE Select | c.582+1G>C | splice_donor intron | N/A | ENSP00000315180.4 | |||
| HNF4A | ENST00000316099.10 | TSL:1 | c.648+1G>C | splice_donor intron | N/A | ENSP00000312987.3 | |||
| HNF4A | ENST00000415691.2 | TSL:1 | c.648+1G>C | splice_donor intron | N/A | ENSP00000412111.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Monogenic diabetes Pathogenic:1
The c.582+1G>C variant in the hepatocyte nuclear factor-4 alpha gene, HNF4A, is predicted to remove a canonical splice donor site in intron 5 of transcript NM_175914.5. This variant is predicted to cause an in-frame deletion of the biologically-relevant exon 5 of 10, removing more than 10% of the protein (PVS1_Strong; PMID: 23348805). Additionally, this variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was also identified in an individual with a clinical history suggestive of HNF4A-MODY (neonatal hypoglycemia that is responsive to diazoxide with negative genetic testing for ABCC8 and KCNJ11)(PP4; internal lab contributors). In summary, c.582+1G>C, meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.0.0, approved 11/16/2022): PVS1_Strong, PM2_Supporting, PP4.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at